04-Oct-2003
HOME, NEWSLETTER
AIM & SCOPE
BOARD OF EDITORS
INSTRUCTIONS
VOL.24, 2003 CONTENTS
VOL.23, 2002
VOL.22, 2001
VOL.21, 2000
VOL.20, 1999
VOL.19, 1998
VOL.18, 1997
ETHOLOGY
PRESS ROOM
CONTACT
SUBSCRIBE - ORDER

NEUROENDOCRINOLOGY LETTERS
including Psychoneuroimmunology, Neuropsychopharmacology,
Reproductive Medicine, Chronobiology
and Human Ethology, ISSN 0172–780X

NEL Vol.24 Nos.3/4, Jun-Aug 2003

ORIGINAL ARTICLE

Peptides of pineal gland and thymus prolong human life

2003; 24:233240
pii: NEL243403A14
PMID: 14523363

[Read pdf 192kb]

Buy article
Check Out

 

Peptides of pineal gland and thymus prolong human life

Vladimir Kh. Khavinson & Vyacheslav G. Morozov

Submitted: January 27, 2003
Accepted: February 22, 2003

Key words:
thymus, epiphysis, peptides, geroprotectors, Thymalin, Epithalamin, aging, life span

 

Abstract

OBJECTIVES AND DESIGN. Researchers of the St. Petersburg Institute of Bioregulation and Gerontology of the North-Western Branch of the Russian Academy of Medical Sciences and the Institute of Gerontology of the Ukrainian Academy of Medical Sciences (Kiev) clinically assessed the geroprotective effects of thymic (Thymalin) and pineal (Epithalamin) peptide bioregulators in 266 elderly and older persons during 6–8 years. The bioregulators were applied for the first 2–3 years of observation.

RESULTS. The obtained results convincingly showed the ability of the bio­regulators to normalize the basic functions of the human organism, i.e. to improve the indices of cardiovascular, endocrine, immune and nervous systems, homeostasis and metabolism. Homeostasis restoration was accompanied by a 2.0–2.4-fold decrease in acute respiratory disease incidence, reduced incidence of the clinical manifestations of ischemic heart disease, hypertension disease, deforming osteoarthrosis and osteoporosis as compared to the control. Such a significant improvement in the health state of the peptide-treated patients correlated with decreased mortality rate during observation: 2.0–2.1-fold in the Thymalin-treated group; 1.6–1.8-fold in the Epithalamin-treated group; 2.5-fold in the patients treated with Thymalin plus Epithalamin as compared to the control. A separate group of patients was treated with Thymalin in combination with Epithalamin annually for 6 years and their mortality rate decreased 4.1 times as compared to the control.

CONCLUSIONS. The obtained data confirmed the high geroprotective efficacy of Thymalin and Epithalamin and the expediency of their application in medicine and social care for health maintenance and age-related pathology prevention in persons over 60 to prolong their active longevity.


__________________________________________________________
Copyright  Neuroendocrinology Letters 2003
Society of Integrated Sciences
All rights reserved. No part may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or ortherwise, without prior written permission from the Editor-in-Chief.
The latest statistics from the www.nel.edu